Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Significant Growth in Short Interest

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw a significant growth in short interest in May. As of May 29th, there was short interest totaling 74,992 shares, a growth of 173.1% from the May 14th total of 27,456 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 283,609 shares, the short-interest ratio is currently 0.3 days.

Shionogi & Co., Ltd. Unsponsored ADR Stock Down 0.3%

SGIOY stock traded down $0.03 during midday trading on Friday, reaching $8.59. The company had a trading volume of 15,857 shares, compared to its average volume of 126,515. The company has a 50 day moving average of $9.80 and a two-hundred day moving average of $9.89. The company has a market capitalization of $14.62 billion, a P/E ratio of 10.74, a PEG ratio of 3.30 and a beta of 0.08. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $7.65 and a 1 year high of $12.00. The company has a current ratio of 5.84, a quick ratio of 5.21 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 14.09%. The business had revenue of $881.71 million for the quarter, compared to the consensus estimate of $895.52 million. On average, equities research analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.81 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a report on Wednesday, April 8th. Zacks Research raised Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research note on Monday, May 25th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.